Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT05081310

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05081310
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Croatia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT05081310. Randomized; no masking; primary purpose treatment. Start 2021-06-01 (actual); primary completion 2024-07-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cryoballoon Isolation of Superior Vena Cava in Paroxysmal Atrial Fibrillation
Acronym
CISPAF
Intervention (Device)
superior vena cava isolation
Intervention (Device)
pulmonary vein isolation
Lead sponsor
University of Zagreb (class: other)

Record details

Record id
cardio:ct-nct05081310
Content hash
189a038417e32199f79f8a17f880cfd69b33be5e74fd422dbadf339f65db2f89